drugset / Trial / NCT04212728
Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to explore the efficacy and safety of autologous adipose-derived mesenchymal stem cells (AMSCs) plus autologous platelet rich plasma (PRP) in the treatment of severe knee osteoarthritis.
Timeline
- Start
- 2019-12-29
- Primary completion
- 2023-12
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Adipose-Derived Mesenchymal Stromal Cells | Cell therapy | — | Intrathecal |
| Background | Platelet Rich Plasma | Other / unclassified | 3 ml | — |